Related Experiment Video
Updated: Jun 26, 2026
08:22
Orthotopic Left Lung Transplantation in Rats
Published on: July 3, 2025
Lung transplantation for COPD - evidence-based?
Samir Lahzami1, John-David Aubert
1Service de pneumilogie, CHUV, Lausanne, Switzerland.
Swiss Medical Weekly
|January 15, 2009
Summary
Lung transplantation offers COPD patients improved lung function and quality of life. Evidence suggests it may also improve survival when appropriate patient selection criteria are used.
Area of Science:
- Pulmonology
- Transplant Surgery
- Medical Research
Background:
- Lung transplantation is a critical treatment for end-stage chronic obstructive pulmonary disease (COPD), representing over a third of global procedures.
- COPD remains the primary indication for lung transplantation worldwide.
- While beneficial for lung function, exercise capacity, and quality of life, the survival benefit of lung transplantation in COPD patients is challenging to definitively establish.
Purpose of the Study:
- To evaluate the impact of lung transplantation on survival in patients with chronic obstructive pulmonary disease (COPD).
- To review the evidence supporting the survival benefit of lung transplantation for COPD patients.
Main Methods:
- Analysis of existing data and indirect evidence regarding lung transplantation outcomes in COPD patients.
- Consideration of methodological challenges, including the lack of randomized controlled trials.
Main Results:
- Lung transplantation in COPD patients demonstrates clear positive effects on lung function, exercise capacity, and quality of life.
- Methodological difficulties, such as the absence of randomized studies, complicate the assessment of survival benefit.
- Indirect but convincing evidence suggests a potential survival benefit for carefully selected COPD patients undergoing lung transplantation.
Conclusions:
- Lung transplantation can significantly enhance the quality of life and post-transplant lifestyle for COPD patients.
- Appropriate selection criteria are crucial for maximizing the benefits, including potential survival advantages, of lung transplantation in COPD.
- Further research may be needed to definitively quantify the survival benefit due to inherent study design limitations.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...